---
title: "Weekly Recap | Guardant Health -0.06%, choppy week ends nearly flat"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298097997.md"
description: "Guardant Health (GH) closed the week down 0.06% at $161.41, lagging the S&P 500 by about 0.15 percentage points. Trading was choppy with no major catalyst. On Monday it dipped to 155.625 and closed at 159.02; Tuesday climbed to 164.41; Wednesday peaked at 168.97 before fading. The stock slid to 154.00 on Friday and then rebounded into the close at 161.41. Weekly amplitude was about 9.36%, so intraday swings were wide even though the week ended nearly flat."
datetime: "2026-09-05T06:55:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298097997.md)
  - [en](https://longbridge.com/en/news/298097997.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298097997.md)
generator: "portal-rs"
---

# Weekly Recap | Guardant Health -0.06%, choppy week ends nearly flat

## The Week

Guardant Health (GH) closed the week down 0.06% at $161.41, lagging the S&P 500 by about 0.15 percentage points. Trading was choppy with no major catalyst. On Monday it dipped to 155.625 and closed at 159.02; Tuesday climbed to 164.41; Wednesday peaked at 168.97 before fading. The stock slid to 154.00 on Friday and then rebounded into the close at 161.41. Weekly amplitude was about 9.36%, so intraday swings were wide even though the week ended nearly flat.

## Analyst Ratings

As of 4 September, 26 firms cover GH: 19 rate it buy, 5 overweight, 1 underweight, and 1 has no opinion, with zero hold ratings. The consensus rating is strong buy, and the consensus target sits at $194.29167, about 20.37% above spot. Targets range from $105 to $225, so dispersion is wide, though most sit above the current price. The stock ranks second out of 53 names in the health-care services industry.

## The Week Ahead

The macro calendar is relatively busy next week. On Tuesday 8 September, the US NFIB small-business optimism index is out. Thursday 10 September brings the 10-year Treasury auction, initial jobless claims, final-demand PPI and core PPI, existing home sales annual rate, wholesale sales, and EIA natural-gas inventories. If these data shift rate expectations, growth-stock pricing conditions could move. No new company earnings are scheduled.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [GH.US](https://longbridge.com/en/quote/GH.US.md)

## Related News & Research

- [Insider Selling: Guardant Health (NASDAQ:GH) Director Sells 69 Shares of Company Stock](https://longbridge.com/en/news/302089930.md)
- [This Guardant Health Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday](https://longbridge.com/en/news/302881838.md)
- [Guardant Health Insider Move: Director’s Stock Sale Sparks Investor Interest](https://longbridge.com/en/news/302052373.md)
- [Guardant Health Shield Blood Test Demonstrates Leading Screening Adherence and CRC Deaths Averted Compared to Stool-Based Tests | GH Stock News](https://longbridge.com/en/news/301975525.md)
- [AI fever ignites a boom in thematic ETFs as fund managers hunt for their next big hit](https://longbridge.com/en/news/302963080.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**